Rely on peer-reviewed journals (NEJM, The Lancet, JAMA), official clinical trial registries (ClinicalTrials.gov), and communications from Eli Lilly
However, resmetirom and semaglutide differ significantly in their mechanisms of action, metabolic effects, safety profiles, and potential clinical applications
This guide covers what GHK-Cu actually is, what the evidence supports, and how its used clinically today
These unregistered, unlicenced products present a potential significant safety risk to patients
Yet, the etiology appears to be multifactorial, as a number of other causative factors have been suggested for KBD, including fungal toxins in grain, iodine deficiency, and contaminated drinking water (52)